Nippon India Pharma Fund - IDCW Option - Portfolio Analysis
- Equity
- Pharma & Healthcare
- Status: Open
Portfolio Overview
As of December 31, 2025
Asset Allocation
Equity: 97.37%Others: 2.63%
Market Cap
Large Cap: 32.01%Mid Cap: 34.55%Small Cap: 29.97%Equity: 0.83%
Number of stocks
36
Top 10 Holdings
116.35% of portfolio
Market Cap of Equity
Large Cap
32.0138%
Mid Cap
34.5525%
Small Cap
29.9652%
Equity
0.8344%
Companies Allocation of Equity
Sun Pharmaceuticals Industries Ltd26.04%
Lupin Ltd14.72%
Divi's Laboratories Ltd13.16%
Cipla Ltd12.78%
Dr Reddy's Laboratories Ltd12.05%
Apollo Hospitals Enterprise Ltd11.06%
Vijaya Diagnostic Centre Ltd7.41%
Medplus Health Services Ltd7.09%
Ajanta Pharma Ltd6.43%
Sai Life Sciences Ltd5.62%
Sector Allocation of Equity
Healthcare97.37%
SIP Amount
Monthly SIP Date
Nippon India Pharma Fund - IDCW Option


Is This Mutual Fund Right for You?
+10k investors used our Suitability Test to get better returns
Fund Suitability Test
Let's Get Started.
Frequently Asked Questions
Everything You Need To Know To Get Started With Confidence
In mutual funds, "market cap allocation" means how assets of the fund are divided among various market capitalizations, which are based on the total market value of the outstanding shares of stock of a company. Market capitalization falls into three major categories: Large-cap, Mid-cap, Small-cap funds.